Detection Technology is expanding with a soon-to-be-completed acquisition of French x-ray detector technology firm MultiX.
MultiX designs, manufactures, and markets x-ray detectors for high-end applications. The purchase includes MultiX's licensing agreements and patents, as well as fixed and current assets. MultiX reported net sales of 800,000 euros ($912,000 U.S.) in 2017. The company employs 17 people at its headquarters in Moirans, France.
Similarly, Detection Technology provides x-ray detectors for medical, security, and industrial applications. The Espoo, Finland-based firm posted net sales of 89 million euros ($101.4 million U.S.) last year and has more than 450 employees, with offices in Finland, China, and the U.S.
MultiX's employees will join Detection Technology. The transaction is scheduled for completion early in January 2019.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
